Karyopharm announces upcoming virtual investor conference participation

Newton, mass., aug. 3, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that richard paulson, president and chief executive officer, will participate on a speaker panel at the 2021 wedbush pacgrow healthcare virtual conference titled, "building back a better commercial infrastructure – selling in covid times" and participate in a fireside chat at the canaccord genuity 41st annual growth conference.
KPTI Ratings Summary
KPTI Quant Ranking